| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2006 | Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. | Hsieh, PC; Davis, ME; Gannon, J; MacGillivray, C; Lee, RT | The Journal of clinical investigation 116(1), 237-248 | | | |
| 2005 | Controlled delivery of PDGF-BB, an endothelial-derived cardiomyocyte survival factor, for myocardial protection using injectable self-assembling peptide nanofibers | Hsieh, PCH; Davis, ME; Lee, RT | CIRCULATION 112-17,U28-U29 | | | |
| 2005 | Custom design of the cardiac microenvironment with biomaterials. | Davis, ME; Hsieh, PC; Grodzinsky, AJ; Lee, RT | Circulation research 97(1), 8-15 | | | |
| 2006 | Endothelial-cardiomyocyte interactions in cardiac development and repair. | Hsieh, PC; Davis, ME; Lisowski, LK; Lee, RT | Annual review of physiology 68, 51-66 | | | |
| 2007 | Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. | Hsieh, PC; Segers, VF; Davis, ME; MacGillivray, C; Gannon, J; Molkentin, JD; Robbins, J; Lee, RT | Nature medicine 13(8), 970-974 | | | |
| 2006 | FGF1/p38 Inhibitor Therapy Induces Cardiomyocyte Mitosis, Reduces Scarring and Rescues Function after Myocardial Infarction | Engel, FB; Hsieh, PC; Lee, RT; Keating, MT | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 103(42), 15546-15551 | | | |
| 2006 | FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction. | Engel, FB; Hsieh, PC; Lee, RT; Keating, MT | Proceedings of the National Academy of Sciences of the United States of America 103(42), 15546-15551 | | | |
| 2006 | Local Controlled Intramyocardial Delivery of PDGF Improves Post-Infarction Ventricular Function without Pulmonary Toxicity | Hsieh, PC; MacGillivray, C; Gannon, J; Cruz, FU; Lee, RT | CIRCULATION 114(7), 637-644 | | | |
| 2006 | Local controlled intramyocardial delivery of platelet-derived growth factor improves postinfarction ventricular function without pulmonary toxicity. | Hsieh, PC; MacGillivray, C; Gannon, J; Cruz, FU; Lee, RT | Circulation 114(7), 637-644 | | | |
| 2006 | Local Myocardial IGF-1 Delivery with Biotinylated Peptide Nanofibers Improves Cell Therapy for Myocardial Infarction | Davis, ME; Hsieh, PC; Takahashi, T; Song, Q; Zhang, S; Kamm, RD; Grodzinsky, AJ; Anversa, P; Lee, RT | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 103(21), 8155-8160 | | | |
| 2006 | Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. | Davis, ME; Hsieh, PC; Takahashi, T; Song, Q; Zhang, S; Kamm, RD; Grodzinsky, AJ; Anversa, P; Lee, RT | Proceedings of the National Academy of Sciences of the United States of America 103(21), 8155-8460 | | | |
| 2009 | Salvianolic acid B-vitamin C synergy in cardiac differentiation from embryonic stem cells. | Chan, SS; Chen, JH; Hwang, SM; Wang, IJ; Li, HJ; Lee, RT; Hsieh, PC | Biochemical and biophysical research communications 387(4), 723-728 | | | |
